Arcturus Therapeutics
ARCT
#9100
Rank
โ‚น16.27 B
Marketcap
โ‚น572.57
Share price
-1.00%
Change (1 day)
-54.36%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2026 (TTM): -โ‚น7.04 Billion

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚น42.35 Million. In 2025 the company made an earning of -โ‚น6.36 Billion, an increase over its 2024 earnings that were of -โ‚น8.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.04 Billion10.79%
2025 -โ‚น6.36 Billion-28.73%
2024 -โ‚น8.92 Billion240.24%
2023 -โ‚น2.62 Billion-298.78%
2022 โ‚น1.31 B-106.79%
2021 -โ‚น19.41 Billion181.83%
2020 -โ‚น6.89 Billion183.72%
2019 -โ‚น2.43 Billion16.93%
2018 -โ‚น2.08 Billion154.5%
2017 -โ‚น0.82 Billion-65.36%
2016 -โ‚น2.36 Billion25.93%
2015 -โ‚น1.87 Billion-41.04%
2014 -โ‚น3.18 Billion219.64%
2013 -โ‚น1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-97.23% Bahamas
NRC Health
NRC
โ‚น1.89 B-125.19%๐Ÿ‡บ๐Ÿ‡ธ USA